
Publication
Strategic asset search and evaluation in biopharma
Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.
Publication
Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.
Publication
Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.
Publication
In today’s volatile market, many startups face the prospect of a down round – a fundraising round at a lower valuation t...
Publication
Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.
© Norton Rose Fulbright US LLP 2025